Donald Trump

All articles by Donald Trump

These 5 companies have the most at stake if drug prices are based on international averages
These 5 companies have the most at stake if drug prices are based on international averages
Alison Kanski
November 2, 2018
6:01 am

The Trump administration has proposed basing Medicare Part B drug prices on what other countries pay.

Novartis revises bonus structure to promote ethical behavior
Novartis revises bonus structure to promote ethical behavior
Alison Kanski
September 21, 2018
10:22 am

The drugmaker has refocused on ethics to move past the Michael Cohen scandal.

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey
Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey
Alison Kanski
June 27, 2018
7:02 pm

Across the political spectrum, most Americans favor President Donald Trump’s proposal to show drug prices in advertisements.

4As O’Brien: How healthcare marketing has changed under Trump
4As O’Brien: How healthcare marketing has changed under Trump
Alison Kanski
May 23, 2018
6:10 pm

Speakers at the Coalition for Healthcare Communication conference discussed how regulations from the White House and FDA have affected healthcare comms.

Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices
Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices
Laura Entis
May 21, 2018
7:13 pm

The White House’s strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.

Drug list prices in DTC ads? Easier said than done
Drug list prices in DTC ads? Easier said than done
Laura Entis
May 16, 2018
6:30 pm

For one of President Trump’s proposals for lowering the cost of drugs, the path to implementation could be long.

5 takeaways from Trump’s drug pricing speech
5 takeaways from Trump’s drug pricing speech
Alison Kanski
May 14, 2018
6:30 pm

Pharma stocks were up after the President went easy on drugmakers.

Five things for pharma marketers to know: Thursday, February 8, 2018
Five things for pharma marketers to know: Thursday, February 8, 2018
Larry Dobrow
February 8, 2018
3:45 pm

FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.

Five things for pharma marketers to know: Wednesday, January 31, 2018
Five things for pharma marketers to know: Wednesday, January 31, 2018
Marc Iskowitz
January 31, 2018
4:14 pm

CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices ‘a priority’

Trump administration raises questions for rare-disease drugmakers
Trump administration raises questions for rare-disease drugmakers
Larry Dobrow
January 17, 2017
12:00 pm

Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.

  • From Our Partners